期刊文献+

从分子极性表面积预测头孢菌素类药物的血浆蛋白结合率 被引量:5

Prediction of plasma protein binding of cephalosporins from polar molecular surface areas
暂未订购
导出
摘要 目的:采用分子结构参数预测头孢菌素类药物的血浆蛋白结合率。方法:用半经验自洽场分子轨道AM1法得到药物分子的优化几何构型,用Monte Carlo法计算分子极性表面积,相关分析采用逐步多元回归分析法。结果:头孢菌素类药物的血浆蛋白结合率(fb)与分子量(MW)和氢键给体表面积(SH)具有良好的相关性,回归方程式为:fb=0.5057+2.861×10-3MW-0.1572SH+4.714×10-3SH2(n=22,r=0.9042)。结论:头孢菌素类药物的血浆蛋白结合率不仅与药物的脂溶性,而且还与形成氢键的能力密切相关。从药物的分子量和极性表面积可以预测头孢菌素类药物的血浆蛋白结合率。 Objective: To predict the plasma protein binding rate of cephalosporins from their molecular structural parameters. Methods: The minimum energy conformations of cephalosporins were obtained from the optimization of the standard molecular geometry with the semiempirical self-consistent field molecular orbital calculation AM1 method; Mont Carlo method was used to calculate the polar molecular surface areas; the stepwise multiple regression analysis was used to obtain the correlation equations. Results: The plasma protein binding rate of cephalosporins (fb) was well correlated with their molecular weights (MW)and surface areas of hydrogen-bonding donors(S,). The regression equation was :fb= 0. 5057+ 2. 861 × 10^-3MW- 0. 1572S, +4. 714 × 10^-3 SH^2 (n = 22, r= 0. 9042). Conclusion: Plasma protein binding of cephalosporins is closely related with their lipophilicity and hydrogen- bonding potential. The plasma protein binding rate of cephalosporins can be predicted from their molecular weights and surface areas of hydrogenbonding donors.
出处 《浙江大学学报(医学版)》 CAS CSCD 2007年第4期386-390,共5页 Journal of Zhejiang University(Medical Sciences)
基金 国家自然科学基金资助项目(30371692) 杭州市属高校重点实验室科技创新项目(2006831H13)
关键词 头孢菌素类/药代动力学 蛋白质结合 模型 统计学 血浆蛋白结合率 分子极性表面积 氢键 Cephalosporins/pharmacokin Protein binding Models, statistical Drug plasmaprotein binding Polar molecular surface areas Hydrogen bond
  • 相关文献

参考文献17

  • 1FICHTL B,NIECIECKI A,WALTER K.Tissue binding versus plasma binding of drugs:General principles and pharmacokinetics consequences[J].Adv Drug Res,1991,20:118-166.
  • 2BENET L Z,KROETZ D L,SHEINER L B.Pharmacokinetics:The dynamics of drug absorption distribution and elimination.In:Goodman & Gilman' The pharmacological basis of therapeutics[M].9ed,New York:McGraw-Hill,1996:3-27.
  • 3HAGE D S,TWEED S A.Recent advances in chromatographic and electrophoretic methods for the study of drug-protein interactions[J].J Chroma B,1997,699:499-525.
  • 4ORAVCOVA J,BOHS B,LINDNER W.Drugprotein binding studies.New trends in analytical and experimental methodology[J].J Chroma B,1996,677:1-28.
  • 5HUANG Y M,ZHANG Z J.Binding study of drug with bovine serum albumin using a combined technique of microdialysis with flowinjection chemiluminescent detection[J].J Pharm Biomed Anal,2004,35:1 293-1 299.
  • 6GOBBURU J V S,SHELVER W H.Quantitative structure-pharmacokinetic relationships (QSPR) of beta blockers derived using neural networks[J].J Pharm Sci,1995,84:862-865.
  • 7DESCHAMPS-LABAT L,PEHOURCQ F,JAGOU M,BANNWARTH B.Relationship between lipophilicity and binding to human serum albumin of arylpropionic acid nonsteroidal anti-inflammatory drugs[J].J Pharm Biomed Anal,1997,16:223-229.
  • 8ZLOTOS G,BUCKER A,JURGENS J,HOLZGRABE U.Protein binding in a congeneric series of antibacterial quinolone derivatives[J].Int J Pharm,1998,169:229-238.
  • 9MAGER D E,JUSKO W J.Quantitative structure-pharmacokinetic/pharmacodynamic relationships of corticosteroids in man[J].J Pharm Sci,2002,91(11):2 441-2 451.
  • 10TURNER J V,MADDALENA D J,CUTLER D J.Pharmacokinetic parameter prediction from drug structure using artificial neural networks[J].Int J Pharm,2004,270:209-219.

二级参考文献22

  • 1傅旭春,孙群.β受体阻断剂的小肠吸收速率与分子结构的相关性[J].浙江大学学报(医学版),2005,34(2):177-180. 被引量:3
  • 2朱本仁,蒙特卡罗方法引论,1987年
  • 3YEE S.In vitro permeability across Caco-2 cells (colo-nic) can predict in vivo (small instinal) absorption in man--fact or myth [J].Pharm Res,1997,14(6):763-766.
  • 4ARTURSSON P,KARLSSON J.Correlation between oral drug absorption in humans and apparent drug per-meability coefficients in human intestinal epithelial (Caco-2) cells[J].Biochem Biophys Res Commun,1991,175:880-885.
  • 5ARTURSSON P, PALM K, LUTHMAN K. Caco-2 monolayers in experimental and theoretical predictions of drug transport [J].Adv Drug Deliv Res,1996,22:67-84.
  • 6TAYLOR D C,POWNALL R,Burke W.The absorption ofβ-adrenoreceptor antagonists in rat in-situ small intestine:the effect of lipophilicity [J].J Pharm Pharmaco,1985,37:280-283.
  • 7LIPISKI C A,LOMBARDO F,Dominy B W,et al.Experimental and computational approaches to eastimate solubility and permeability in drug discovery and deve-lopment settings [J].Adv Drug Deliv Res,1997,23:3-25.
  • 8CLARK D E.Rapid calculation of polar molecular surface area and its application to the prediction of transport phenomena.1.Prediction of intestinal absorption [J].J Pharm Sci 1999,88:807-814.
  • 9Stenberg P,Luthman K,Artursson P.Vertual screening of intestinal drug permeability [J].J Contr Rel,2000,65:231-243.
  • 10ZHAO Y H,LE J,ABRAHAM M H,et al.Evaluation of human intestinal absorption data and subsequent derivation of a quantitative structure-activity relationship (QSAR) with the Abraham descriptors [J].J Pharm Sci,2001,90(6):749-784.

共引文献15

同被引文献94

引证文献5

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部